We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFS
451
DELISTED
Discover Financial Services
DFS
| $4.5M | 0.03% |
+38,044
| New | +$4.3M |
|
|
SWAV
452
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $4.49M | 0.03% |
+23,671
| New | +$3.87M |
|
453
Liberty Latin America Class C
LILAK
$1.55B
| $4.49M | 0.03% |
350,304
+50,502
| +17% | +$648K |
|
|
COR
454
DELISTED
Coresite Realty Corporation
COR
| $4.48M | 0.03% |
+33,260
| New | +$4.15M |
|
455
Domo
DOMO
$161M
| $4.45M | 0.03% |
55,093
+7,271
| +15% | +$476K |
|
|
TCS
456
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $4.41M | 0.03% |
+22,524
| New | +$4.68M |
|
457
Ardelyx
ARDX
$1.25B
| $4.39M | 0.03% |
579,045
-418,901
| -42% | -$3.1M |
|
|
GBT
458
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.38M | 0.03% |
125,095
-7,445
| -6% | -$291K |
|
|
EGIO
459
DELISTED
Edgio, Inc. Common Stock
EGIO
| $4.38M | 0.03% |
+34,753
| New | +$4.59M |
|
|
CSLT
460
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $4.38M | 0.03% |
1,664,436
+1,084,684
| +187% | +$2.02M |
|
461
National Health Investors
NHI
$3.84B
| $4.35M | 0.03% |
64,840
-15,823
| -20% | -$1.1M |
|
462
Genco Shipping & Trading
GNK
$1.09B
| $4.34M | 0.03% |
230,034
-25,759
| -10% | -$398K |
|
|
NTUS
463
DELISTED
Natus Medical Inc
NTUS
| $4.31M | 0.03% |
165,925
-100,827
| -38% | -$2.74M |
|
464
Universal Display
OLED
$3.81B
| $4.31M | 0.03% |
19,377
-206
| -1% | -$45.1K |
|
465
Ooma
OOMA
$571M
| $4.29M | 0.03% |
227,392
-7,633
| -3% | -$138K |
|
|
USX
466
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $4.27M | 0.03% |
497,003
+68,847
| +16% | +$732K |
|
467
Invitation Homes
INVH
$17.6B
| $4.25M | 0.03% |
113,969
-380,882
| -77% | -$13.5M |
|
468
Scansource
SCSC
$1.13B
| $4.24M | 0.03% |
150,760
+18,451
| +14% | +$549K |
|
|
ILPT
469
Industrial Logistics Properties Trust
ILPT
$601M
| $4.24M | 0.03% |
162,120
+104,353
| +181% | +$2.62M |
|
470
First Bancorp
FBP
$4.39B
| $4.22M | 0.03% |
354,067
| – | – |
|
471
Usana Health Sciences
USNA
$412M
| $4.19M | 0.03% |
40,870
-2,039
| -5% | -$205K |
|
472
HubSpot
HUBS
$11.4B
| $4.13M | 0.03% |
7,089
+1,871
| +36% | +$976K |
|
473
STAAR Surgical
STAA
$1.14B
| $4.13M | 0.03% |
+27,049
| New | +$3.56M |
|
474
WaFd
WAFD
$2.69B
| $4.12M | 0.03% |
129,611
-429
| -0.3% | -$14K |
|
475
TriCo Bancshares
TCBK
$1.84B
| $4.11M | 0.03% |
96,479
+8,227
| +9% | +$382K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.